News Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 04:34:49 2025-01-21 am EST			5-day change	1st Jan Change
565.40 ^DKK	+2.56%		-5.22%	-10.06%

Jan. 03	New Year, Soft Start
Jan. 03	BNP Paribas Exane Cuts Novo Nordisk PT, Maintains at Outperform	MT

NOVO NORDISK : UBS gives a Buy rating	02:02am	ZD
Novo Nordisk A/S, Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence	Jan. 20	AQ
Novo Nordisk A/S - share repurchase programme	Jan. 20	GL
Novo Nordisk is far too cheap according to equity strategist - Di	Jan. 20	FW
Health Care Drops on Regulatory Fears - Health Care Roundup	Jan. 17	DJ
Sector Update: Health Care Stocks Decline Late Afternoon	Jan. 17	MT
What Wegovy's inclusion in Medicare price negotiation means for patients, company	Jan. 17	RE
NOVO NORDISK : Bernstein remains Neutral	Jan. 17	ZD
Sector Update: Health Care Stocks Softer Friday Afternoon	Jan. 17	MT
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	Jan. 17	MT
Sector Update: Health Care	Jan. 17	MT
Top Midday Stories: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks; Supreme Court Allows TikTok Ban to Take Effect	Jan. 17	MT
Global markets live: Citigroup, GM, Meta, Apple, Novo Nordisk...	Jan. 17
European Equities Traded in the US as American Depositary Receipts Edge Higher Friday	Jan. 17	MT
NOVO NORDISK : JP Morgan keeps its Buy rating	Jan. 17	ZD
USA: 15 new drugs on the negotiation list	Jan. 17	CF
Investerum Strategic Value declined 1.26 percent in December - increased in Novo Nordisk	Jan. 17	FW
NOVO NORDISK : UBS keeps its Buy rating	Jan. 17	ZD
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	Jan. 17	MT
EU Panel Starts Probe on Novo Nordisk Weight Loss Drugs' Links to Rare Eye Disease	Jan. 17	MT
Wegovy, Ozempic Targeted by US for Medicare Price Cuts	Jan. 17	MT
LVMH back ahead of Novo Nordisk on the stock market	Jan. 17
Novo Nordisk Says Higher-Dose Wegovy Achieves Greater Weight Loss in Trial -- Update	Jan. 17	DJ
Terry Smith's portfolio for 2025	Jan. 17
US targets Novo Nordisk's Ozempic and Wegovy for Medicare price talks	Jan. 17	RE

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Wegovy, Ozempic Targeted by US for Medicare Price Cuts

January 17, 2025 at 10:36 am EST

Cagrisema sends Novo Nordisk to the mat

December 20, 2024 at 06:20 am EST

NOVO NORDISK : CagriSema results are not worthy of panic

December 20, 2024 at 09:14 am EST